Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Gastroenterology
Crohn's Disease
Clinical Trial Seeking Crohn's Disease Patients
Is your Crohn’s disease active?
New Research Takes Aim At Crohn's Disease
Study Investigating a novel oral treatment for Crohn's disease
Crohn's disease research study
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Is your Crohn’s disease active?
A Multi-Center Study of Adult patients 18 years of age or older with moderate to severe Crohn's disease.
Stomach & Intestines: Do you have Crohn’s disease or ulcerative colitis?
Crohn's Disease
Crohn's Disease
Crohn's Disease - Working for a Better Tomorrow
Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
Crohn's Disease
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Is your Crohn’s disease active?
A Clinical Research Study for Adults with Moderately-to Severely-Active Crohn’s Disease
Do you have Crohn's Disease?
Do You Have Crohn's Disease? Have You Received Infliximab (Remicade) Therapy?
Do you suffer from Crohn's disease and have been unable to find a successful treatment option?
Is your Crohn’s disease active?
Crohn’s Disease- Ages 6-17 years old
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease.
Protocol M02-403
A Phase III, multicenter, placebo-controlled, randomized, double-blind study to evaluate the safety and efficacy of PROCHYMAL (ex vivo cultured adult human mesenchymal stem cells) intravenous infusion for the induction of remission in subjects experiencing treatment-refractory moderate-to-severe Crohns disease [603].
A Phase III, multicenter, placebo-controlled, randomized, double-blind study to evaluate the safety and efficacy of PROCHYMAL (ex vivo cultured adult human mesenchymal stem cells) intravenous infusion for the induction of remission in subjects experiencing treatment-refractory moderate-to-severe Crohns disease [603].
A Phase IIIb multicentre, open label induction and double blind comparison of two maintenance schedules evaluating clinical benefit and tolerability of certolizumab pegol, a pegylated Fab fragment of humanized antibody to tumor necrosis factor(TNF) over 26 weeks in patients suffering from Crohn's disease with prior loss of response or intolerance to infliximab.[RPCE05F1501]
Double-blind, Randomized, Multicenter, Placebo controlled Phase II Study of Efficacy and Safety of HMPL 004 in Subjects with Active Moderate Crohn's Disease [200500401]
Is your Crohn’s disease active?
Multi-site Trial of Azathioprine Dosing in Crohn?Æs Disease
Multi-site Trial of Azathioprine Dosing in Crohn's Disease
Do you suffer from Crohn's Disease?
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Crohn’s Disease?
Do you have Crohn's Disease?
Do you have suffer from Crohn's Disease?
Don’t let Crohn’s Disease keep you from your favorite activities
Is your Crohn’s disease active?
Research Study for Crohn's Disease
Do you suffer from Crohn's Disease?
Humira for Crohn's Disease
Research trial now enrolling for Humira ® for Crohn's Disease
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Men and women 18-65 with active Crohn's disease wanted for study
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Is your Crohn’s disease active?
Is your Crohn’s disease active?
